IOMED, INC.

Patent Owner

Compare Create Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 186
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1180

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,788,031 Method and device for the iontophoretic delivery of a drugOct 25, 06Jul 22, 14[A61N, A61M]
5,399,875 Liquid gauging apparatus and remote sensor interrogationMay 28, 93Mar 21, 95[G01N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2008/0009,501 Methods for treating neoplastic, angiogenic, fibroblastic, and/or immunosuppressive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicamentsABANSep 10, 07Jan 10, 08[A61P, A61K]
2008/0003,260 Use of 5-fluorourcil, delivered by iontophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skinABANSep 10, 07Jan 03, 08[A61P, A61K]
7,252,655 Ocular iontophoretic apparatus handleExpiredAug 03, 01Aug 07, 07[A61M]
2006/0189,919 Ocular iontophoretic apparatus with handleABANApr 19, 06Aug 24, 06[A61N, A61M]
2005/0197,618 IMPROVED BUFFER GEL FOR IONTOPHORESIS ELECTRODESABANMar 03, 04Sep 08, 05[A61N, A61K]
2005/0153,969 METHODS FOR TREATING NEOPLASTIC, ANGIOGENIC, FIBROBLASTIC, AND/OR IMMUNOSUPPRESSIVE OCULAR IRREGULARITIES VIA ADMINISTRATION OF METHOTREXATE BASED MEDICAMENTS, AND OCULAR IONTOPHORETIC DEVICES FOR DELIVERING METHOTREXATE BASED MEDICAMENTABANJan 13, 04Jul 14, 05[A61K]
2005/0153,994 THE USE OF 5-FLUOROURCIL, DELIVERED BY IONTOPHORESIS AS AN INHIBITOR OF CELL PROLIFERATION IN THE EYE, BULBAR AND PALPEBRAL CONJUNCTIVA, EYELID, PERI-ORBITAL SOFT TISSUES AND SKINABANJan 13, 04Jul 14, 05[A61K]
6,728,573 Ocular iontophoretic apparatus handleExpiredJun 22, 00Apr 27, 04[A61N]
6,697,668 Ocular iontophoretic device and method for using the sameExpiredJan 25, 01Feb 24, 04[A61N]
6,579,276 Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (VEGF) using the sameExpiredJan 22, 01Jun 17, 03[A61N]
6,546,283 High current density iontophoretic device and method of use thereofExpiredOct 18, 00Apr 08, 03[A61N]
6,539,251 Ocular iontophoretic apparatusExpiredAug 03, 01Mar 25, 03[A61B]
2003/0023,228 Ocular iontophoretic device and method for using the sameABANJul 20, 01Jan 30, 03[A61M]
6,391,015 Method for measuring the cutaneous electrical resistance of a patient subjected to transdermal administration of medicineExpiredMay 17, 99May 21, 02[A61M]
6,319,240 Methods and apparatus for ocular iontophoresisExpiredMay 25, 99Nov 20, 01[A61N]
6,062,915 Nondeforming electrode connectorExpiredFeb 05, 99May 16, 00[H01R]
5,983,132 Ionophoretic device for transdermal administration of medicaments, and disposable assembly forming part of such deviceExpiredMay 12, 97Nov 09, 99[A61N]
5,899,875 Device for percutaneous administration of medicaments for treating male impotenceExpiredMay 12, 97May 04, 99[A61N, A61F]
5,889,396 Method and device for measuring the quantity of an active principle contained in a reservoirExpiredOct 31, 96Mar 30, 99[G01N]
5,846,217 Iontophoretic bioelectrode and method of using sameExpiredJul 29, 97Dec 08, 98[A61N]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.